Abstract:Variable lymphocyte receptors (VLRs), the leucine-rich repeat (LRR)-based antigen receptors of jawless fish, have great utility in a wide variety of biochemical and biological applications, similar to classical Ig-based antibodies. VLR-based reagents may be particularly useful when traditional antibodies are not available. An anti-idiotype lamprey VLR, VLR39, has previously been identified that recognizes the heavy-chain CDR3 of the B-cell receptor (BCR) of a leukemic clone from a patient with chronic lymphocy… Show more
“…A variety of monoclonal VLR antibodies have been successfully generated against diverse classes of antigens including purified proteins [7], cell surface determinants [8,9], anti-idiotypic antibody targets [10], glycan antigens [11,12], extracellular matrix antigens [13], viral antigens [14], and bacterial cell wall antigens [15], demonstrating the practical potential of VLR antibodies. The lamprey immune response has been characterized, [16] and this information has been incorporated into inoculation schemes designed to optimize monoclonal selection.…”
Section: Introductionmentioning
confidence: 99%
“…Size variation upon testing a random library clones is consistent with the capture of a diverse set of clones during library preparation. High background in empty vector control: If background staining with the secondary Ab is high, a different secondary Ab reagent should to be used 10…”
Lamprey antibodies, the variable lymphocyte receptor B proteins (VLRB), have unique properties that make them promising alternatives to jawed vertebrate immunoglobulin domain antibodies. These leucinerich repeat proteins exhibit a diversity on par with that of jawed vertebrate antibodies but are structurally completely distinct. VLRB antibodies have been successfully raised to a variety of antigens. A procedure for high-throughput screening of full-length lamprey VLRB libraries using whole cells is described here. Lamprey antibodies against cell surface antigens can be generated and screened quickly using this method.
“…A variety of monoclonal VLR antibodies have been successfully generated against diverse classes of antigens including purified proteins [7], cell surface determinants [8,9], anti-idiotypic antibody targets [10], glycan antigens [11,12], extracellular matrix antigens [13], viral antigens [14], and bacterial cell wall antigens [15], demonstrating the practical potential of VLR antibodies. The lamprey immune response has been characterized, [16] and this information has been incorporated into inoculation schemes designed to optimize monoclonal selection.…”
Section: Introductionmentioning
confidence: 99%
“…Size variation upon testing a random library clones is consistent with the capture of a diverse set of clones during library preparation. High background in empty vector control: If background staining with the secondary Ab is high, a different secondary Ab reagent should to be used 10…”
Lamprey antibodies, the variable lymphocyte receptor B proteins (VLRB), have unique properties that make them promising alternatives to jawed vertebrate immunoglobulin domain antibodies. These leucinerich repeat proteins exhibit a diversity on par with that of jawed vertebrate antibodies but are structurally completely distinct. VLRB antibodies have been successfully raised to a variety of antigens. A procedure for high-throughput screening of full-length lamprey VLRB libraries using whole cells is described here. Lamprey antibodies against cell surface antigens can be generated and screened quickly using this method.
Human B cell adaptor for phosphoinositide 3-kinase (BCAP) is identified as an adaptor protein expressed in B cells and plays a critical immunomodulatory role in B cell receptor signaling and humoral immune response. In the current study, a homolog of BCAP (Lja-BCAP) was identified in Lampetra japonica. The open reading frame of Lja-BCAP contains 2181bp nucleotides and encodes a protein of 726 amino acids. After being stimulated by mixed bacteria, the mRNA and protein expression levels of Lja-BCAP and the activation levels of tyrosine kinases increased significantly in peripheral blood lymphocytes, gills and supraneural myeloid bodies, respectively. However, after the knockdown of Lja-BCAP by RNAi in vivo, the activation of tyrosine kinases was inhibited in the above tissues, which indicated that Lja-BCAP participated in the anti-bacterial immune response of lampreys. After lipopolysaccharide (LPS) stimulation, the expression of Lja-BCAP in peripheral blood lymphocytes, gills and supraneural myeloid bodies were significantly up-regulated 2.5, 2.2, and 11.1 times (p < 0.05) compared to the control group, respectively; while after phytohemagglutinin (PHA) stimulation, the up-regulation of Lja-BCAP was only detected in peripheral blood lymphocytes. The above results show that Lja-BCAP mainly participates in the LPS-mediated immune response of lampreys.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.